2023 BIO CEO & Investor Conference
35th Annual
About
Contact:
Tel: +1 239.682.8500
Email: ml@nls-pharma.com
(C) 2023 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 USD | +9.02% | +5.94% | -69.49% |
Feb. 23 | NLS Pharmaceutics Files Plan to Regain Nasdaq Listing Compliance | MT |
Dec. 06 | NLS Pharmaceutics AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 BIO CEO & Investor Conference
35th Annual
About
Contact:
Tel: +1 239.682.8500
Email: ml@nls-pharma.com
(C) 2023 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-69.49% | 7.8M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |